Neil Vasdev ACSF, FRSC, FSNMMI | |
---|---|
Born | Canada |
Alma mater | McMaster University |
Known for | PET radiopharmaceuticals |
Scientific career | |
Fields | Radiochemistry, nuclear medicine and molecular imaging |
Institutions | Centre for Addiction and Mental Health; University of Toronto; Harvard Medical School; Massachusetts General Hospital; Northeastern University. |
Neil Vasdev is a Canadian and American radiochemist and expert in nuclear medicine and molecular imaging, particularly in the application of PET. Radiotracers developed by the Vasdev Lab are in preclinical use worldwide, and many have been translated for first-in-human neuroimaging studies.[1] He is the director and chief radiochemist of the Brain Health Imaging Centre and director of the Azrieli Centre for Neuro-Radiochemistry at the Centre for Addiction and Mental Health (CAMH). He is the Tier 1 Canada Research Chair in Radiochemistry and Nuclear Medicine, the endowed Azrieli Chair in Brain and Behaviour and Professor of Psychiatry at the University of Toronto.[2] Vasdev has been featured on Global News,[3] CTV,[4] CNN,[5] New York Times,[6] Toronto Star[7] and the Globe and Mail for his innovative research program.
Vasdev began his independent faculty career at CAMH/University of Toronto in 2004. From 2011–2017 he served as the director of radiochemistry and an associate centre director at the Massachusetts General Hospital and served as an associate professor in the department of radiology at Harvard Medical School from 2012–2022. He was recruited back to CAMH and the University of Toronto in November 2017.
:0
was invoked but never defined (see the help page).:2
was invoked but never defined (see the help page).:3
was invoked but never defined (see the help page).